Alpha Esports Announces Expansion into Brazil; Signs Launch Partnership with Mais Esports, Brazil’s Largest Esports Media Company

Partnership will leverage GamerzArena Platform for Esports Tournaments & Co-marketing Campaigns VANCOUVER,…

Alpha Esports Signs Binding Letter of Intent to Acquire 100% of eDoxa Inc.

eDoxa’s AI platform enables Alpha’s platforms to promote fair play with new…

GT Biopharma Announces Sponsored Research Agreement With Dr. Jeffrey S. Miller Of The University Of Minnesota

Deepening relationship between GT Biopharma and Dr. Jeffrey Miller TriKE™ improves FT538 iPSC…

GT Biopharma CEO, Tony Cataldo to Present at Sir Anthony Ritossa’s Global Family Office Investment Summit

BEVERLY HILLS, Calif, June 24, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT…

GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2021 Raymond James Human Health Innovation Conference

57% of patients experienced significant reduction in AML/MDS cancer cell burden Up…

Dr. Jeffrey S. Miller to Present on Progress of GTB-3550 TriKE™ Phase I Trial Accompanying GT Biopharma’s Company Presentation at Raymond James Human Health Innovation Conference

BEVERLY HILLS, Calif., June 21, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT…

GT Biopharma to Present at Raymond James Human Health Innovation Conference

BEVERLY HILLS, Calif., June 16, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT…

GT Biopharma Announces Update On The Commencement Of The GTB-3550 TriKE™ Monotherapy Phase 2 Clinical Trial And Solid Tumor TriKE™ Product Candidates

BEVERLY HILLS, Calif., May 12, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…

Beyond Medical Subsidiary Micron Technologies Achieves “Amazon’s Choice” Designation and Begins to Accept Bitcoin Payments for its Made in Canada Face Masks

VANCOUVER, BC, April 27, 2021 /CNW/ – Beyond Medical Technologies Inc. (“Beyond…

GT Biopharma Announces Enrollment Of Patient 10 in GTB-3550 TriKE™ Phase I/II Clinical Trial

BEVERLY HILLS, Calif., April 8, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…